RADNOR, Pa. (AP) _ Marinus Pharmaceuticals Inc. (MRNS) on Wednesday reported a loss of $12.5 million in its first quarter.
On a per-share basis, the Radnor, Pennsylvania-based company said it had a loss of 24 cents.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 21 cents per share.
The company's shares closed at $4.94. A year ago, they were trading at $4.44.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNS at https://www.zacks.com/ap/MRNS